Targeting tumours with genetically enhanced T lymphocytes

被引：415
作者：
Sadelain, M
Rivière, I
Brentjens, R
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
来源：
NATURE REVIEWS CANCER | 2003年 / 3卷 / 01期
关键词：
D O I：
10.1038/nrc971
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The genetic modification of T lymphocytes is an important approach to investigating normal T-cell biology and to increasing antitumour immunity. A number of genetic strategies aim to increase the recognition of tumour antigens, enhance antitumour activities and prevent T-cell malfunction. T cells can also be engineered to increase safety, as well as to express markers that can be tracked by non-invasive imaging technologies. Genetically modified T cells are therefore proving to be of great value for basic immunology and experimental immunotherapy.
引用
收藏
页码：35 / 45
页数：11
相关论文
共 50 条
[41]   Targeting human tumours with antigen-specific cytotoxic T-cells [J].
Rickinson, AB .
BRITISH JOURNAL OF CANCER, 1999, 80 :51-56
[42]   Targeting the Tumour Vasculature with CAR T-Cells for Treatment of Solid Tumours [J].
Camicia, Rosalba ;
Ricardo, Carolina P. ;
Sanchez-Nieto, Juan M. ;
Labbe, Roman ;
Keogh, Andrea ;
Gargiulo, Luciana ;
Guijarro-Leach, Juan J. ;
Whitworth, Katharine ;
Robinson, Joe ;
Zhuang, Xiaodong ;
Jinx, Elizabeth ;
Bystrom, Jonas ;
Sharif, Maria ;
Nagy, Zsuzsanna ;
Tordo, Julie ;
Mccoy, Ryan ;
Sharpe, Michaela ;
Kallmeier, Robert ;
Bicknell, Roy ;
Lee, Steven ;
Munye, Mustafa M. .
MOLECULAR THERAPY, 2019, 27 (04) :63-64
[43]   Splenic T Regulatory Lymphocytes Are Reduced in Genetically Hypertensive Rats Associated with Central Sympathoexcitation [J].
Katsuki, Masato ;
Hirooka, Yoshitaka ;
Kishi, Takuya ;
Sunagawa, Kenji .
HYPERTENSION, 2013, 62 (03)
[44]   Cellular Immunotherapy for Carcinoma Using Genetically Modified EGFR-Specific T Lymphocytes [J].
Zhou, Xikun ;
Li, Jing ;
Wang, Zhen ;
Chen, Zhongwen ;
Qiu, Ji ;
Zhang, Yinbing ;
Wang, Wei ;
Ma, Yu ;
Huang, Nongyu ;
Cui, Kaijun ;
Li, Jiong ;
Wei, Yu-quan .
NEOPLASIA, 2013, 15 (05) :544-+
[45]   Therapeutic potential of genetically modified T-lymphocytes in Crohn's disease. [J].
van Montfrans, C ;
Velde, AAR ;
Spits, H ;
Hooijberg, E ;
van Deventer, SJ .
GASTROENTEROLOGY, 2000, 118 (04) :A873-A873
[46]   Autoreactive T lymphocytes in multiple sclerosis - Pathogenic role and therapeutic targeting [J].
Stinissen, P ;
Zhang, JW ;
Vandevyver, C ;
Raus, J .
NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, :113-119
[47]   Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting [J].
Stinissen, P ;
Raus, J .
ACTA NEUROLOGICA BELGICA, 1999, 99 (01) :65-69
[48]   Targeting T and B lymphocytes with radiolabelled antibodies for diagnostic and therapeutic applications [J].
Malviya, G. ;
Galli, F. ;
Sonni, I. ;
Pacilio, M. ;
Signore, A. .
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (06) :654-676
[49]   Spectral karyotyping demonstrates genetically unstable skin-homing T lymphocytes in cutaneous T cell lymphoma [J].
Padilla-Nash, H ;
Wu, K ;
Just, H ;
Ried, T ;
Thestrup-Pedersen, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (03) :751-751
[50]   Enhanced responses of glycosylphosphatidylinositol anchor-deficient T lymphocytes [J].
Hazenbos, WLW ;
Murakami, Y ;
Nishimura, J ;
Takeda, J ;
Kinoshita, T .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3810-3815
12345